History & Overview Annual Report President's Pages Center News Community Affairs
Make a Gift Yankees Universe Fund Fred's Team Donating Blood & Platelets Volunteering Thrift Shop Park Avenue Potluck Cookbook
Press Releases Information for Journalists News@MSKCC
Manhattan New Jersey Long Island Westchester
Working at Memorial Sloan-Kettering Work Sites College Recruitment About Nursing Job Fairs & Career Days Job Search & Apply Online
Making an Appointment

The Retinoblastoma Program of the Ophthalmic Oncology Service at Memorial Sloan-Kettering Cancer Center has managed more patients than any other cancer center in the world. The Service has helped to advance the use of cutting-edge vision-saving techniques, including external beam radiation, radioactive plaques (a therapy in which radioactive discs are inserted directly into the affected eye), laser therapy, cryotherapy (a therapy in which smaller tumors are frozen), and chemoreduction (a therapy that uses chemotherapy to shrink the tumor).

Our Team
Our Team
From Left: Anabela C. Rodrigues, medical secretary; Maria Hinton, nurse practitioner; Alexis L. Leitenberger, nurse; David H Abramson, Chief, Ophthalmic Oncology Service; (seated on table) Jocabed Villa, ophthalmic technician, and Harriet Rosengarten, medical secretary; Freddi Goodman, medical secretary; Matthew Hawk; Diane M. Murphy, ophthalmic tech: Nursing; Juana Abreu, medical secretary

With more than 12,000 examinations for retinoblastoma, our ophthalmic oncologist has unmatched experience in the diagnosis of retinoblastoma and of conditions that look like retinoblastoma.

Our multidisciplinary approach allows children to receive all their pediatric oncology care, ophthalmic oncology, and radiation oncology treatments under general anesthesia at Memorial Sloan-Kettering. Once a diagnosis has been made, our patients receive treatment in a suite of examination and treatment rooms dedicated exclusively to retinoblastoma.

Innovative Chemotherapy Treatments

For children with retinoblastoma in their eyes only, we use a mild form of chemotherapy to avoid or delay radiation therapy whenever possible. We have introduced a new treatment for certain patients, in which chemotherapy is injected around the eye instead of being given intravenously. This can be more effective and also avoids some of the side effects of intravenous chemotherapy. This new treatment is discussed in greater detail in the journal Ophthalmology.

Unique Treatment Approaches for Metastatic Retinoblastoma

Our Publications
Visit PubMed for
our journal articles

Retinoblastoma tumors that have metastasized outside the eye are often described as being incurable. However, at Memorial Sloan-Kettering we have successfully treated children with disease that has spread to their bones, bone marrow, and liver with intensive chemotherapy. The results have been very promising. A new intrathecal medication (given into the fluid that surrounds the brain and spinal cord) is available for patients whose retinoblastoma has spread to the surface of the brain. This procedure is discussed in the journal Cancer.

You may wish to have a formal consultation at the Retinoblastoma Program of Memorial Sloan-Kettering. Feel free to contact us at 212-639-2153; we will be happy to discuss your child's condition with you and organize a formal consultation if you want one.


Last Updated: Jan. 17, 2006
PrintEmail This Page